Eastgate Biotech Corp Stock Price To Sales
| ETBIDelisted Stock | USD 0 0.00 0.00% |
Eastgate Biotech Corp fundamentals help investors to digest information that contributes to Eastgate Biotech's financial success or failures. It also enables traders to predict the movement of Eastgate Stock. The fundamental analysis module provides a way to measure Eastgate Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eastgate Biotech stock.
Eastgate |
Eastgate Biotech Corp Company Price To Sales Analysis
Eastgate Biotech's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Eastgate Biotech Price To Sales | 1.49 X |
Most of Eastgate Biotech's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eastgate Biotech Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Eastgate Biotech Corp has a Price To Sales of 1.4949 times. This is 93.01% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The price to sales for all United States stocks is 86.91% higher than that of the company.
Eastgate Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eastgate Biotech's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Eastgate Biotech could also be used in its relative valuation, which is a method of valuing Eastgate Biotech by comparing valuation metrics of similar companies.Eastgate Biotech is currently under evaluation in price to sales category among its peers.
Eastgate Fundamentals
| Operating Margin | (74.40) % | |||
| Current Valuation | 18.92 M | |||
| Shares Outstanding | 2.06 B | |||
| Price To Earning | (0.10) X | |||
| Price To Sales | 1.49 X | |||
| EBITDA | (3.55 M) | |||
| Net Income | (2.98 M) | |||
| Cash And Equivalents | 4.91 K | |||
| Total Debt | 1.67 M | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (389.48 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | -3039.35 | |||
| Market Capitalization | 205.75 K | |||
| Retained Earnings | (14.63 M) | |||
| Working Capital | (1.94 M) | |||
| Current Asset | 167 K | |||
| Current Liabilities | 2.11 M |
About Eastgate Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eastgate Biotech Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eastgate Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eastgate Biotech Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Eastgate Stock
If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |